Literature DB >> 25272520

[Mutations in the GATA4 gen in patients with non-syndromic congenital heart disease].

Diana Carolina Orjuela Quintero, Federico Núñez, Víctor Caicedo, Sonia Pachón, Marleny Salazar Salazar.   

Abstract

Congenital heart diseases are defined as any heart or large vessel structural abnormality resulting from abnormal embryonic development, usually described between the 3rd and 10th week of gestation. They comprise the second cause of death in children under a year of age in Colombia, with a prevalence of 7.5-9.5 per 1,000 births, including live and still births. We analyzed 33 heart tissue samples collected at the Clínica Shaio (Bogotá, Colombia). Blood and tissue samples were collected from patients with non-syndromic congenital heart disease. Tissue was isolated near the defect. Electropherograms obtained from samples were analyzed using bioinformatic tools: ChromasPro and ClustalW. The whole gen covering its six exons was analyzed in forward and reverse orientation. We identified 17 mutations, including five non-synonymous sequence changes, one synonymous variant and one variation in the 5' UTR, three intronic changes and seven deletions. We found no evidence of gene GATA4 somatic sequence variants in any of the samples analyzed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25272520

Source DB:  PubMed          Journal:  Invest Clin        ISSN: 0535-5133            Impact factor:   0.683


  2 in total

1.  Correlation between GATA4 gene polymorphism and congenital heart disease.

Authors:  Xue-Yong Yang; Xiao-Yong Jing; Zhe Chen; Ying-Long Liu
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  GATA4 screening in Iranian patients of various ethnicities affected with congenital heart disease: Co-occurrence of a novel de novo translocation (5;7) and a likely pathogenic heterozygous GATA4 mutation in a family with autosomal dominant congenital heart disease.

Authors:  Samira Kalayinia; Majid Maleki; Hassan Rokni-Zadeh; Majid Changi-Ashtiani; Hassan Ahangar; Alireza Biglari; Tina Shahani; Nejat Mahdieh
Journal:  J Clin Lab Anal       Date:  2019-05-22       Impact factor: 2.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.